{ event: "article_read", name: `Blood esinophils, FeNO, and the modifiable risk of asthma attacks`, author: ``, tags: `Luftveiene | Astma`, publication_date: ``, interaction_type: "content" }
Blood esinophils, FeNO, and the modifiable risk of asthma attacks
Recorded webinar
In Sanofi’s RespTalks webinar in January, Professor Ian Pavord & Dr. Simon Couillard discussed the concept of treatable traits as a new approach to managing asthma. In this recording, we hear Dr. Couillard presenting his views on how the treatable traits approach can aid the management of severe asthma.
Speaker: Simon Couillard, MD
Simon Couillard, MD, is a Canadian specialist in respiratory medicine and a clinical teacher at the Université de Sherbooke. He finished a two-year clinical research fellowship in severe asthma with the University of Oxford under the supervision of Professor Pavord, and has started a joint Oxford-Leiden PhD on risk prediction in asthma.
